Locally Advanced or Metastatic EGFR T790M+ NSCLC
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic EGFR T790M+ NSCLC
| Record | Firm | Date |
|---|---|---|
| Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours (NCT02454933) | AstraZeneca | 2015-07-15 |
Track Locally Advanced or Metastatic EGFR T790M+ NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.